Digital Therapeutics Market By Product (Software, Devices), By Application (Cardiovascular Diseases, Central Nervous System (CNS) Disease, Diabetes, Gastrointestinal Disorders (GID), Mental Health, Neurology, Obesity, Ophthalmology, Respiratory Diseases, Smoking Cessation, Others ), By Distribution Channel (Business to Business, Business to Customer ), By End Users (Patients, Healthcare Providers, Payers, Employers, Other (Fitness and Wellness Centers, Gym, Etc.), By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, The Benelux Union, Rest of Europe, China, Japan, India, Australia, New Zealand, South Korea Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027
Industry Trends
Global digital therapeutics market was valued at US$ 1658.3 million in 2018 and is expected to reach US$ 9,121.8 million by 2027 growing at an estimated CAGR of 21.1% over the forecast period. Growing need to control healthcare costs along with rising incidence of chronic diseases are factors that assist the global digital therapeutics market. Digital therapeutics is essentially deliver evidence-based therapeutic interventions to patients to manage, treat, or prevent a chronic disease or disorder. The basal insulin dose calculator for patients suffering from Type 2 diabetes is an ideal instance for digital therapeutics.
The increasing demand for patient specific outcomes by healthcare agencies is another factor assisting the growth of digital therapeutics market. Traditional pharmaceutical and medtech companies can make the decision to capitalize on the opportunistic factors presented by digital therapeutics. The sooner the entry, the greater the potential. The first-mover advantage will allow life science organizations to shape and define the industry. Some of the pharmaceutical and med-tech companies are teaming with other companies to build digital capabilities either through acquisition strategy or licensing them from other companies. Such factors is anticipated to aid the overall growth of digital therapeutics market.
However, most of the pharma companies have not yet ventured in digital therapeutics market. This is mainly because they are trying to be more cautious in the highly regulated pharma industry. However, if this organizations shy away from this great opportunity for a longer period, they will risk losing crucial market share to the emerging healthcare technology companies. With such a technological innovation, pharmaceutical and medical device multinationals in the coming years will not just sell drugs to healthcare professional but also provide a bundle of digital therapies, medicines and services for the benefit of patients, healthcare professional as well as healthcare payers.
However, lack of awareness among consumers regarding digital therapeutics is one of the factors critically impacting the market growth. Delivering prevention along with awareness information through text message or some online media portal can effectively improve the consumer base of digital therapeutics. The pregnant women in Mali has helped to reduce maternal and perinatal mortality by almost 30% through the penetration of digital therapeutics.
North America accounted for more than 40% of the global digital therapeutics market. The company named Big Health is working with more than two dozen self-insured corporations in the United States to offer Sleepio to their employees. This initiative will help in closing the treatment gap of people suffering from chronic insomnia. Pear Therapeutics based in Boston and San Francisco developed prescription-based digital treatments for substance use disorder, schizophrenia, generalized anxiety disorder and post-traumatic stress disorder. The company’s reSET therapy for treatment of substance use disorders is the first prescription digital therapeutic cleared by the Food and Drug Administration (FDA).
The report provides both, qualitative and quantitative research of global digital therapeutics market, as well as provides worthy insights into the rational scenario and favored development methods adopted by key contenders. The report also offers extensive research on the key players in global diesel engine and gas engine market and detailed insights on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes its headquarter, competitors, product/service type, application and specification, pricing, and gross margin.
Global Digital Therapeutics Market Revenue, 2019 - 2027
Competitive Landscape
The primary market participants in global digital therapeutics market include Adherium, BigHealth, BLUE MESA HEALTH, CANARY HEALTH, Chrono Therapeutics Inc., Diabetes Digital Media Ltd, Digital Therapeutics, Inc., Dthera Sciences, Firstbeat, GINGER.IO, Glooko, Inc., Limbix , Livongo Health, MANGO HEALTH, Merck & Co., Inc., Noom, Inc., Novartis AG, Omada Health, Inc., Propeller Health, Proteus Digital Health, WellDoc, Inc. among others.
Global Digital Therapeutics Market
By Products
- Software
- Devices
By Application
- Cardiovascular Diseases
- Central Nervous System (CNS) Disease
- Diabetes
- Gastrointestinal Disorders (GID)
- Mental Health
- Neurology
- Obesity
- Ophthalmology
- Respiratory Diseases
- Smoking Cessation
- Others
By Distribution Channel
- Business to Business
- Business to Customer
By End User
- Patients
- Healthcare Providers
- Payers
- Employers
- Other (Fitness and Wellness Centers, Gym, Etc.)
By Geography
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2013 - 2017
1.2.2. Base
Year: 2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Digital Therapeutics Market
6. Market Synopsis:
Digital Therapeutics Market
7. Digital Therapeutics Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in
Digital Therapeutics Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Digital Therapeutics Market
7.6. Industry
Gross Margin Overview
7.7. Porter’s
Five Force Analysis
7.8. PESTEL
Analysis
7.9. Value
Chain Analysis
7.10. Pricing
Analysis, By Region (2018)
7.10.1. North
America
7.10.1.1. U.S
7.10.1.2. Canada
7.10.1.3. Mexico
7.10.2. Europe
7.10.2.1. France
7.10.2.2. The UK
7.10.2.3. Spain
7.10.2.4. Germany
7.10.2.5. Italy
7.10.2.6. Nordic Countries
7.10.2.6.1. Denmark
7.10.2.6.2. Finland
7.10.2.6.3. Iceland
7.10.2.6.4. Sweden
7.10.2.6.5. Norway
7.10.2.7. Benelux Union
7.10.2.7.1. Belgium
7.10.2.7.2. The
Netherlands
7.10.2.7.3. Luxembourg
7.10.3. Asia
Pacific
7.10.3.1. China
7.10.3.2. Japan
7.10.3.3. India
7.10.3.4. New Zealand
7.10.3.5. Australia
7.10.3.6. South Korea
7.10.3.7. Southeast Asia
7.10.3.7.1. Indonesia
7.10.3.7.2. Thailand
7.10.3.7.3. Malaysia
7.10.3.7.4. Singapore
7.10.3.7.5. Rest
of Southeast Asia
7.10.4. Middle
East and Africa
7.10.4.1. Saudi Arabia
7.10.4.2. UAE
7.10.4.3. Egypt
7.10.4.4. Kuwait
7.10.4.5. South Africa
7.10.5. Latin
America
7.10.5.1. Brazil
7.10.5.2. Argentina
8. Global Digital Therapeutics Market Analysis and Forecasts,
2019 – 2027
8.1. Overview
8.1.1. Global
Digital Therapeutics Market Revenue (US$ Mn)
8.2. Global
Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products
8.2.1. Software
8.2.1.1. Definition
8.2.1.2. Market Penetration, 2018
8.2.1.3. Market Estimation, 2013 – 2018
8.2.1.4. Market Forecast, 2019 – 2027
8.2.1.5. Compound Annual Growth Rate (CAGR)
8.2.1.6. Regional Bifurcation
8.2.1.6.1. North
America
8.2.1.6.1.1. Market
Estimation, 2013 – 2018
8.2.1.6.1.2. Market
Forecast, 2019 – 2027
8.2.1.6.2. Europe
8.2.1.6.2.1. Market
Estimation, 2013 – 2018
8.2.1.6.2.2. Market
Forecast, 2019 – 2027
8.2.1.6.3. Asia
Pacific
8.2.1.6.3.1. Market
Estimation, 2013 – 2018
8.2.1.6.3.2. Market
Forecast, 2019 – 2027
8.2.1.6.4. Middle
East and Africa
8.2.1.6.4.1. Market
Estimation, 2013 – 2018
8.2.1.6.4.2. Market
Forecast, 2019 – 2027
8.2.1.6.5. Latin
America
8.2.1.6.5.1. Market
Estimation, 2013 – 2018
8.2.1.6.5.2. Market
Forecast, 2019 – 2027
8.2.2. Devices
8.2.2.1. Definition
8.2.2.2. Market Penetration, 2018
8.2.2.3. Market Estimation, 2013 – 2018
8.2.2.4. Market Forecast, 2019 – 2027
8.2.2.5. Compound Annual Growth Rate (CAGR)
8.2.2.6. Regional Bifurcation
8.2.2.6.1. North
America
8.2.2.6.1.1. Market
Estimation, 2013 – 2018
8.2.2.6.1.2. Market
Forecast, 2019 – 2027
8.2.2.6.2. Europe
8.2.2.6.2.1. Market
Estimation, 2013 – 2018
8.2.2.6.2.2. Market
Forecast, 2019 – 2027
8.2.2.6.3. Asia
Pacific
8.2.2.6.3.1. Market
Estimation, 2013 – 2018
8.2.2.6.3.2. Market
Forecast, 2019 – 2027
8.2.2.6.4. Middle
East and Africa
8.2.2.6.4.1. Market
Estimation, 2013 – 2018
8.2.2.6.4.2. Market
Forecast, 2019 – 2027
8.2.2.6.5. Latin
America
8.2.2.6.5.1. Market
Estimation, 2013 – 2018
8.2.2.6.5.2. Market
Forecast, 2019 – 2027
8.3. Key
Segment for Channeling Investments
8.3.1. By
Products
9. Global Digital Therapeutics Market Analysis and Forecasts,
2019 – 2027
9.1. Overview
9.2. Global
Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application
9.2.1. Cardiovascular
Diseases
9.2.1.1. Definition
9.2.1.2. Market Penetration, 2018
9.2.1.3. Market Estimation, 2013 – 2018
9.2.1.4. Market Forecast, 2019 – 2027
9.2.1.5. Compound Annual Growth Rate (CAGR)
9.2.1.6. Regional Bifurcation
9.2.1.6.1. North
America
9.2.1.6.1.1. Market
Estimation, 2013 – 2018
9.2.1.6.1.2. Market
Forecast, 2019 – 2027
9.2.1.6.2. Europe
9.2.1.6.2.1. Market
Estimation, 2013 – 2018
9.2.1.6.2.2. Market
Forecast, 2019 – 2027
9.2.1.6.3. Asia
Pacific
9.2.1.6.3.1. Market
Estimation, 2013 – 2018
9.2.1.6.3.2. Market
Forecast, 2019 – 2027
9.2.1.6.4. Middle
East and Africa
9.2.1.6.4.1. Market
Estimation, 2013 – 2018
9.2.1.6.4.2. Market
Forecast, 2019 – 2027
9.2.1.6.5. Latin
America
9.2.1.6.5.1. Market
Estimation, 2013 – 2018
9.2.1.6.5.2. Market
Forecast, 2019 – 2027
9.2.2. Central
Nervous System (CNS) Diseases
9.2.2.1. Definition
9.2.2.2. Market Penetration, 2018
9.2.2.3. Market Estimation, 2013 – 2018
9.2.2.4. Market Forecast, 2019 – 2027
9.2.2.5. Compound Annual Growth Rate (CAGR)
9.2.2.6. Regional Bifurcation
9.2.2.6.1. North
America
9.2.2.6.1.1. Market
Estimation, 2013 – 2018
9.2.2.6.1.2. Market
Forecast, 2019 – 2027
9.2.2.6.2. Europe
9.2.2.6.2.1. Market
Estimation, 2013 – 2018
9.2.2.6.2.2. Market
Forecast, 2019 – 2027
9.2.2.6.3. Asia
Pacific
9.2.2.6.3.1. Market
Estimation, 2013 – 2018
9.2.2.6.3.2. Market
Forecast, 2019 – 2027
9.2.2.6.4. Middle
East and Africa
9.2.2.6.4.1. Market
Estimation, 2013 – 2018
9.2.2.6.4.2. Market
Forecast, 2019 – 2027
9.2.2.6.5. Latin
America
9.2.2.6.5.1. Market
Estimation, 2013 – 2018
9.2.2.6.5.2. Market
Forecast, 2019 – 2027
9.2.3. Diabetes
9.2.3.1. Definition
9.2.3.2. Market Penetration, 2018
9.2.3.3. Market Estimation, 2013 – 2018
9.2.3.4. Market Forecast, 2019 – 2027
9.2.3.5. Compound Annual Growth Rate (CAGR)
9.2.3.6. Regional Bifurcation
9.2.3.6.1. North
America
9.2.3.6.1.1. Market
Estimation, 2013 – 2018
9.2.3.6.1.2. Market
Forecast, 2019 – 2027
9.2.3.6.2. Europe
9.2.3.6.2.1. Market
Estimation, 2013 – 2018
9.2.3.6.2.2. Market
Forecast, 2019 – 2027
9.2.3.6.3. Asia
Pacific
9.2.3.6.3.1. Market
Estimation, 2013 – 2018
9.2.3.6.3.2. Market
Forecast, 2019 – 2027
9.2.3.6.4. Middle
East and Africa
9.2.3.6.4.1. Market
Estimation, 2013 – 2018
9.2.3.6.4.2. Market
Forecast, 2019 – 2027
9.2.3.6.5. Latin
America
9.2.3.6.5.1. Market
Estimation, 2013 – 2018
9.2.3.6.5.2. Market
Forecast, 2019 – 2027
9.2.4. Gastrointestinal
Disorders (GID)
9.2.4.1. Definition
9.2.4.2. Market Penetration, 2018
9.2.4.3. Market Estimation, 2013 – 2018
9.2.4.4. Market Forecast, 2019 – 2027
9.2.4.5. Compound Annual Growth Rate (CAGR)
9.2.4.6. Regional Bifurcation
9.2.4.6.1. North
America
9.2.4.6.1.1. Market
Estimation, 2013 – 2018
9.2.4.6.1.2. Market
Forecast, 2019 – 2027
9.2.4.6.2. Europe
9.2.4.6.2.1. Market
Estimation, 2013 – 2018
9.2.4.6.2.2. Market
Forecast, 2019 – 2027
9.2.4.6.3. Asia
Pacific
9.2.4.6.3.1. Market
Estimation, 2013 – 2018
9.2.4.6.3.2. Market
Forecast, 2019 – 2027
9.2.4.6.4. Middle
East and Africa
9.2.4.6.4.1. Market
Estimation, 2013 – 2018
9.2.4.6.4.2. Market
Forecast, 2019 – 2027
9.2.4.6.5. Latin
America
9.2.4.6.5.1. Market
Estimation, 2013 – 2018
9.2.4.6.5.2. Market
Forecast, 2019 – 2027
9.2.5. Mental Health
9.2.5.1. Definition
9.2.5.2. Market Penetration, 2018
9.2.5.3. Market Estimation, 2013 – 2018
9.2.5.4. Market Forecast, 2019 – 2027
9.2.5.5. Compound Annual Growth Rate (CAGR)
9.2.5.6. Regional Bifurcation
9.2.5.6.1. North
America
9.2.5.6.1.1. Market
Estimation, 2013 – 2018
9.2.5.6.1.2. Market
Forecast, 2019 – 2027
9.2.5.6.2. Europe
9.2.5.6.2.1. Market
Estimation, 2013 – 2018
9.2.5.6.2.2. Market
Forecast, 2019 – 2027
9.2.5.6.3. Asia
Pacific
9.2.5.6.3.1. Market
Estimation, 2013 – 2018
9.2.5.6.3.2. Market
Forecast, 2019 – 2027
9.2.5.6.4. Middle
East and Africa
9.2.5.6.4.1. Market
Estimation, 2013 – 2018
9.2.5.6.4.2. Market
Forecast, 2019 – 2027
9.2.5.6.5. Latin
America
9.2.5.6.5.1. Market
Estimation, 2013 – 2018
9.2.5.6.5.2. Market
Forecast, 2019 – 2027
9.2.6. Neurology
9.2.6.1. Definition
9.2.6.2. Market Penetration, 2018
9.2.6.3. Market Estimation, 2013 – 2018
9.2.6.4. Market Forecast, 2019 – 2027
9.2.6.5. Compound Annual Growth Rate (CAGR)
9.2.6.6. Regional Bifurcation
9.2.6.6.1. North
America
9.2.6.6.1.1. Market
Estimation, 2013 – 2018
9.2.6.6.1.2. Market
Forecast, 2019 – 2027
9.2.6.6.2. Europe
9.2.6.6.2.1. Market
Estimation, 2013 – 2018
9.2.6.6.2.2. Market
Forecast, 2019 – 2027
9.2.6.6.3. Asia
Pacific
9.2.6.6.3.1. Market
Estimation, 2013 – 2018
9.2.6.6.3.2. Market
Forecast, 2019 – 2027
9.2.6.6.4. Middle
East and Africa
9.2.6.6.4.1. Market
Estimation, 2013 – 2018
9.2.6.6.4.2. Market
Forecast, 2019 – 2027
9.2.6.6.5. Latin
America
9.2.6.6.5.1. Market
Estimation, 2013 – 2018
9.2.6.6.5.2. Market
Forecast, 2019 – 2027
9.2.7. Obesity
9.2.7.1. Definition
9.2.7.2. Market Penetration, 2018
9.2.7.3. Market Estimation, 2013 – 2018
9.2.7.4. Market Forecast, 2019 – 2027
9.2.7.5. Compound Annual Growth Rate (CAGR)
9.2.7.6. Regional Bifurcation
9.2.7.6.1. North
America
9.2.7.6.1.1. Market
Estimation, 2013 – 2018
9.2.7.6.1.2. Market
Forecast, 2019 – 2027
9.2.7.6.2. Europe
9.2.7.6.2.1. Market
Estimation, 2013 – 2018
9.2.7.6.2.2. Market
Forecast, 2019 – 2027
9.2.7.6.3. Asia
Pacific
9.2.7.6.3.1. Market
Estimation, 2013 – 2018
9.2.7.6.3.2. Market
Forecast, 2019 – 2027
9.2.7.6.4. Middle
East and Africa
9.2.7.6.4.1. Market
Estimation, 2013 – 2018
9.2.7.6.4.2. Market
Forecast, 2019 – 2027
9.2.7.6.5. Latin
America
9.2.7.6.5.1. Market
Estimation, 2013 – 2018
9.2.7.6.5.2. Market
Forecast, 2019 – 2027
9.2.8. Ophthalmology
9.2.8.1. Definition
9.2.8.2. Market Penetration, 2018
9.2.8.3. Market Estimation, 2013 – 2018
9.2.8.4. Market Forecast, 2019 – 2027
9.2.8.5. Compound Annual Growth Rate (CAGR)
9.2.8.6. Regional Bifurcation
9.2.8.6.1. North
America
9.2.8.6.1.1. Market
Estimation, 2013 – 2018
9.2.8.6.1.2. Market
Forecast, 2019 – 2027
9.2.8.6.2. Europe
9.2.8.6.2.1. Market
Estimation, 2013 – 2018
9.2.8.6.2.2. Market
Forecast, 2019 – 2027
9.2.8.6.3. Asia
Pacific
9.2.8.6.3.1. Market
Estimation, 2013 – 2018
9.2.8.6.3.2. Market
Forecast, 2019 – 2027
9.2.8.6.4. Middle
East and Africa
9.2.8.6.4.1. Market
Estimation, 2013 – 2018
9.2.8.6.4.2. Market
Forecast, 2019 – 2027
9.2.8.6.5. Latin
America
9.2.8.6.5.1. Market
Estimation, 2013 – 2018
9.2.8.6.5.2. Market
Forecast, 2019 – 2027
9.2.9. Respiratory
Diseases
9.2.9.1. Definition
9.2.9.2. Market Penetration, 2018
9.2.9.3. Market Estimation, 2013 – 2018
9.2.9.4. Market Forecast, 2019 – 2027
9.2.9.5. Compound Annual Growth Rate (CAGR)
9.2.9.6. Regional Bifurcation
9.2.9.6.1. North
America
9.2.9.6.1.1. Market
Estimation, 2013 – 2018
9.2.9.6.1.2. Market
Forecast, 2019 – 2027
9.2.9.6.2. Europe
9.2.9.6.2.1. Market
Estimation, 2013 – 2018
9.2.9.6.2.2. Market
Forecast, 2019 – 2027
9.2.9.6.3. Asia
Pacific
9.2.9.6.3.1. Market
Estimation, 2013 – 2018
9.2.9.6.3.2. Market
Forecast, 2019 – 2027
9.2.9.6.4. Middle
East and Africa
9.2.9.6.4.1. Market
Estimation, 2013 – 2018
9.2.9.6.4.2. Market
Forecast, 2019 – 2027
9.2.9.6.5. Latin
America
9.2.9.6.5.1. Market
Estimation, 2013 – 2018
9.2.9.6.5.2. Market
Forecast, 2019 – 2027
9.2.10. Smoking
Cessation
9.2.10.1. Definition
9.2.10.2. Market Penetration, 2018
9.2.10.3. Market Estimation, 2013 – 2018
9.2.10.4. Market Forecast, 2019 – 2027
9.2.10.5. Compound Annual Growth Rate (CAGR)
9.2.10.6. Regional Bifurcation
9.2.10.6.1. North
America
9.2.10.6.1.1. Market
Estimation, 2013 – 2018
9.2.10.6.1.2. Market
Forecast, 2019 – 2027
9.2.10.6.2. Europe
9.2.10.6.2.1. Market
Estimation, 2013 – 2018
9.2.10.6.2.2. Market
Forecast, 2019 – 2027
9.2.10.6.3. Asia
Pacific
9.2.10.6.3.1. Market
Estimation, 2013 – 2018
9.2.10.6.3.2. Market
Forecast, 2019 – 2027
9.2.10.6.4. Middle
East and Africa
9.2.10.6.4.1. Market
Estimation, 2013 – 2018
9.2.10.6.4.2. Market
Forecast, 2019 – 2027
9.2.10.6.5. Latin
America
9.2.10.6.5.1. Market
Estimation, 2013 – 2018
9.2.10.6.5.2. Market
Forecast, 2019 – 2027
9.2.11. Others
9.2.11.1. Definition
9.2.11.2. Market Penetration, 2018
9.2.11.3. Market Estimation, 2013 – 2018
9.2.11.4. Market Forecast, 2019 – 2027
9.2.11.5. Compound Annual Growth Rate (CAGR)
9.2.11.6. Regional Bifurcation
9.2.11.6.1. North
America
9.2.11.6.1.1. Market
Estimation, 2013 – 2018
9.2.11.6.1.2. Market
Forecast, 2019 – 2027
9.2.11.6.2. Europe
9.2.11.6.2.1. Market
Estimation, 2013 – 2018
9.2.11.6.2.2. Market
Forecast, 2019 – 2027
9.2.11.6.3. Asia
Pacific
9.2.11.6.3.1. Market
Estimation, 2013 – 2018
9.2.11.6.3.2. Market
Forecast, 2019 – 2027
9.2.11.6.4. Middle
East and Africa
9.2.11.6.4.1. Market
Estimation, 2013 – 2018
9.2.11.6.4.2. Market
Forecast, 2019 – 2027
9.2.11.6.5. Latin
America
9.2.11.6.5.1. Market
Estimation, 2013 – 2018
9.2.11.6.5.2. Market
Forecast, 2019 – 2027
9.3. Key
Segment for Channeling Investments
9.3.1. By
Application
10. Global Digital Therapeutics Market Analysis and Forecasts,
2019 – 2027
10.1. Overview
10.2. Global
Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
10.2.1. Business
to Business
10.2.1.1. Definition
10.2.1.2. Market Penetration, 2018
10.2.1.3. Market Estimation, 2013 – 2018
10.2.1.4. Market Forecast, 2019 – 2027
10.2.1.5. Compound Annual Growth Rate (CAGR)
10.2.1.6. Regional Bifurcation
10.2.1.6.1. North
America
10.2.1.6.1.1. Market
Estimation, 2013 – 2018
10.2.1.6.1.2. Market
Forecast, 2019 – 2027
10.2.1.6.2. Europe
10.2.1.6.2.1. Market
Estimation, 2013 – 2018
10.2.1.6.2.2. Market
Forecast, 2019 – 2027
10.2.1.6.3. Asia
Pacific
10.2.1.6.3.1. Market
Estimation, 2013 – 2018
10.2.1.6.3.2. Market
Forecast, 2019 – 2027
10.2.1.6.4. Middle
East and Africa
10.2.1.6.4.1. Market
Estimation, 2013 – 2018
10.2.1.6.4.2. Market
Forecast, 2019 – 2027
10.2.1.6.5. Latin
America
10.2.1.6.5.1. Market
Estimation, 2013 – 2018
10.2.1.6.5.2. Market
Forecast, 2019 – 2027
10.2.2. Business
to Customer
10.2.2.1. Definition
10.2.2.2. Market Penetration, 2018
10.2.2.3. Market Estimation, 2013 – 2018
10.2.2.4. Market Forecast, 2019 – 2027
10.2.2.5. Compound Annual Growth Rate (CAGR)
10.2.2.6. Regional Bifurcation
10.2.2.6.1. North
America
10.2.2.6.1.1. Market
Estimation, 2013 – 2018
10.2.2.6.1.2. Market
Forecast, 2019 – 2027
10.2.2.6.2. Europe
10.2.2.6.2.1. Market
Estimation, 2013 – 2018
10.2.2.6.2.2. Market
Forecast, 2019 – 2027
10.2.2.6.3. Asia
Pacific
10.2.2.6.3.1. Market
Estimation, 2013 – 2018
10.2.2.6.3.2. Market
Forecast, 2019 – 2027
10.2.2.6.4. Middle
East and Africa
10.2.2.6.4.1. Market
Estimation, 2013 – 2018
10.2.2.6.4.2. Market
Forecast, 2019 – 2027
10.2.2.6.5. Latin
America
10.2.2.6.5.1. Market
Estimation, 2013 – 2018
10.2.2.6.5.2. Market
Forecast, 2019 – 2027
10.3. Key
Segment for Channeling Investments
10.3.1. By
Distribution Channel
11. Global Digital Therapeutics Market Analysis and Forecasts,
2019 – 2027
11.1. Overview
11.2. Global
Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User
11.2.1. Patients
11.2.1.1. Definition
11.2.1.2. Market Penetration, 2018
11.2.1.3. Market Estimation, 2013 – 2018
11.2.1.4. Market Forecast, 2019 – 2027
11.2.1.5. Compound Annual Growth Rate (CAGR)
11.2.1.6. Regional Bifurcation
11.2.1.6.1. North
America
11.2.1.6.1.1. Market
Estimation, 2013 – 2018
11.2.1.6.1.2. Market
Forecast, 2019 – 2027
11.2.1.6.2. Europe
11.2.1.6.2.1. Market
Estimation, 2013 – 2018
11.2.1.6.2.2. Market
Forecast, 2019 – 2027
11.2.1.6.3. Asia
Pacific
11.2.1.6.3.1. Market
Estimation, 2013 – 2018
11.2.1.6.3.2. Market
Forecast, 2019 – 2027
11.2.1.6.4. Middle
East and Africa
11.2.1.6.4.1. Market
Estimation, 2013 – 2018
11.2.1.6.4.2. Market
Forecast, 2019 – 2027
11.2.1.6.5. Latin
America
11.2.1.6.5.1. Market
Estimation, 2013 – 2018
11.2.1.6.5.2. Market
Forecast, 2019 – 2027
11.2.2. Healthcare
Providers
11.2.2.1. Definition
11.2.2.2. Market Penetration, 2018
11.2.2.3. Market Estimation, 2013 – 2018
11.2.2.4. Market Forecast, 2019 – 2027
11.2.2.5. Compound Annual Growth Rate (CAGR)
11.2.2.6. Regional Bifurcation
11.2.2.6.1. North
America
11.2.2.6.1.1. Market
Estimation, 2013 – 2018
11.2.2.6.1.2. Market
Forecast, 2019 – 2027
11.2.2.6.2. Europe
11.2.2.6.2.1. Market
Estimation, 2013 – 2018
11.2.2.6.2.2. Market
Forecast, 2019 – 2027
11.2.2.6.3. Asia
Pacific
11.2.2.6.3.1. Market
Estimation, 2013 – 2018
11.2.2.6.3.2. Market
Forecast, 2019 – 2027
11.2.2.6.4. Middle
East and Africa
11.2.2.6.4.1. Market
Estimation, 2013 – 2018
11.2.2.6.4.2. Market
Forecast, 2019 – 2027
11.2.2.6.5. Latin
America
11.2.2.6.5.1. Market
Estimation, 2013 – 2018
11.2.2.6.5.2. Market
Forecast, 2019 – 2027
11.2.3. Payers
11.2.3.1. Definition
11.2.3.2. Market Penetration, 2018
11.2.3.3. Market Estimation, 2013 – 2018
11.2.3.4. Market Forecast, 2019 – 2027
11.2.3.5. Compound Annual Growth Rate (CAGR)
11.2.3.6. Regional Bifurcation
11.2.3.6.1. North
America
11.2.3.6.1.1. Market
Estimation, 2013 – 2018
11.2.3.6.1.2. Market
Forecast, 2019 – 2027
11.2.3.6.2. Europe
11.2.3.6.2.1. Market
Estimation, 2013 – 2018
11.2.3.6.2.2. Market
Forecast, 2019 – 2027
11.2.3.6.3. Asia
Pacific
11.2.3.6.3.1. Market
Estimation, 2013 – 2018
11.2.3.6.3.2. Market
Forecast, 2019 – 2027
11.2.3.6.4. Middle
East and Africa
11.2.3.6.4.1. Market
Estimation, 2013 – 2018
11.2.3.6.4.2. Market
Forecast, 2019 – 2027
11.2.3.6.5. Latin
America
11.2.3.6.5.1. Market
Estimation, 2013 – 2018
11.2.3.6.5.2. Market
Forecast, 2019 – 2027
11.2.4. Employers
11.2.4.1. Definition
11.2.4.2. Market Penetration, 2018
11.2.4.3. Market Estimation, 2013 – 2018
11.2.4.4. Market Forecast, 2019 – 2027
11.2.4.5. Compound Annual Growth Rate (CAGR)
11.2.4.6. Regional Bifurcation
11.2.4.6.1. North
America
11.2.4.6.1.1. Market
Estimation, 2013 – 2018
11.2.4.6.1.2. Market
Forecast, 2019 – 2027
11.2.4.6.2. Europe
11.2.4.6.2.1. Market
Estimation, 2013 – 2018
11.2.4.6.2.2. Market
Forecast, 2019 – 2027
11.2.4.6.3. Asia
Pacific
11.2.4.6.3.1. Market
Estimation, 2013 – 2018
11.2.4.6.3.2. Market
Forecast, 2019 – 2027
11.2.4.6.4. Middle
East and Africa
11.2.4.6.4.1. Market
Estimation, 2013 – 2018
11.2.4.6.4.2. Market
Forecast, 2019 – 2027
11.2.4.6.5. Latin
America
11.2.4.6.5.1. Market
Estimation, 2013 – 2018
11.2.4.6.5.2. Market
Forecast, 2019 – 2027
11.2.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
11.2.5.1. Definition
11.2.5.2. Market Penetration, 2018
11.2.5.3. Market Estimation, 2013 – 2018
11.2.5.4. Market Forecast, 2019 – 2027
11.2.5.5. Compound Annual Growth Rate (CAGR)
11.2.5.6. Regional Bifurcation
11.2.5.6.1. North
America
11.2.5.6.1.1. Market
Estimation, 2013 – 2018
11.2.5.6.1.2. Market
Forecast, 2019 – 2027
11.2.5.6.2. Europe
11.2.5.6.2.1. Market
Estimation, 2013 – 2018
11.2.5.6.2.2. Market
Forecast, 2019 – 2027
11.2.5.6.3. Asia
Pacific
11.2.5.6.3.1. Market
Estimation, 2013 – 2018
11.2.5.6.3.2. Market
Forecast, 2019 – 2027
11.2.5.6.4. Middle
East and Africa
11.2.5.6.4.1. Market
Estimation, 2013 – 2018
11.2.5.6.4.2. Market
Forecast, 2019 – 2027
11.2.5.6.5. Latin
America
11.2.5.6.5.1. Market
Estimation, 2013 – 2018
11.2.5.6.5.2. Market
Forecast, 2019 – 2027
11.3. Key
Segment for Channeling Investments
11.3.1. By End
User
12. North America Digital Therapeutics Market Analysis and
Forecasts, 2019 - 2027
12.1. Overview
12.1.1. North
America Digital Therapeutics Market Revenue (US$ Mn)
12.2. North
America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products
12.2.1. Software
12.2.2. Devices
12.3. North
America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By
Application
12.3.1. Cardiovascular
Diseases
12.3.2. Central
Nervous System (CNS) Diseases
12.3.3. Diabetes
12.3.4. Gastrointestinal
Disorders (GID)
12.3.5. Mental
Health
12.3.6. Neurology
12.3.7. Obesity
12.3.8. Ophthalmology
12.3.9. Respiratory
Diseases
12.3.10. Smoking
Cessation
12.3.11. Others
12.4. North
America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
12.4.1. Business
to Business
12.4.2. Business
to Customer
12.5. North
America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User
12.5.1. Patients
12.5.2. Healthcare
Providers
12.5.3. Payers
12.5.4. Employers
12.5.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
12.6. North
America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1. U.S Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
12.6.1.1.1. Software
12.6.1.1.2. Devices
12.6.1.2. U.S Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.1.2.1. Cardiovascular
Diseases
12.6.1.2.2. Central
Nervous System (CNS) Diseases
12.6.1.2.3. Diabetes
12.6.1.2.4. Gastrointestinal
Disorders (GID)
12.6.1.2.5. Mental
Health
12.6.1.2.6. Neurology
12.6.1.2.7. Obesity
12.6.1.2.8. Ophthalmology
12.6.1.2.9. Respiratory
Diseases
12.6.1.2.10. Smoking
Cessation
12.6.1.2.11. Others
12.6.1.3. U.S Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
12.6.1.3.1. Business
to Business
12.6.1.3.2. Business
to Customer
12.6.1.4. U.S Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.1.4.1. Patients
12.6.1.4.2. Healthcare
Providers
12.6.1.4.3. Payers
12.6.1.4.4. Employers
12.6.1.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
12.6.2. Canada
12.6.2.1. Canada Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
12.6.2.1.1. Software
12.6.2.1.2. Devices
12.6.2.2. Canada Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.2.2.1. Cardiovascular
Diseases
12.6.2.2.2. Central
Nervous System (CNS) Diseases
12.6.2.2.3. Diabetes
12.6.2.2.4. Gastrointestinal
Disorders (GID)
12.6.2.2.5. Mental
Health
12.6.2.2.6. Neurology
12.6.2.2.7. Obesity
12.6.2.2.8. Ophthalmology
12.6.2.2.9. Respiratory
Diseases
12.6.2.2.10. Smoking
Cessation
12.6.2.2.11. Others
12.6.2.3. Canada Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
12.6.2.3.1. Business
to Business
12.6.2.3.2. Business
to Customer
12.6.2.4. Canada Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.2.4.1. Patients
12.6.2.4.2. Healthcare
Providers
12.6.2.4.3. Payers
12.6.2.4.4. Employers
12.6.2.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
12.6.3. Mexico
12.6.3.1. Mexico Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
12.6.3.1.1. Software
12.6.3.1.2. Devices
12.6.3.2. Mexico Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.3.2.1. Cardiovascular
Diseases
12.6.3.2.2. Central
Nervous System (CNS) Diseases
12.6.3.2.3. Diabetes
12.6.3.2.4. Gastrointestinal
Disorders (GID)
12.6.3.2.5. Mental
Health
12.6.3.2.6. Neurology
12.6.3.2.7. Obesity
12.6.3.2.8. Ophthalmology
12.6.3.2.9. Respiratory
Diseases
12.6.3.2.10. Smoking
Cessation
12.6.3.2.11. Others
12.6.3.3. Mexico Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
12.6.3.3.1. Business
to Business
12.6.3.3.2. Business
to Customer
12.6.3.4. Mexico Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.3.4.1. Patients
12.6.3.4.2. Healthcare
Providers
12.6.3.4.3. Payers
12.6.3.4.4. Employers
12.6.3.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
12.6.4. Rest of
North America
12.6.4.1. Rest of North America Digital Therapeutics Market Revenue (US$
Mn) and Forecasts, By Products
12.6.4.1.1. Software
12.6.4.1.2. Devices
12.6.4.2. Rest of North America Digital Therapeutics Market Revenue (US$
Mn) and Forecasts, By Application
12.6.4.2.1. Cardiovascular
Diseases
12.6.4.2.2. Central
Nervous System (CNS) Diseases
12.6.4.2.3. Diabetes
12.6.4.2.4. Gastrointestinal
Disorders (GID)
12.6.4.2.5. Mental
Health
12.6.4.2.6. Neurology
12.6.4.2.7. Obesity
12.6.4.2.8. Ophthalmology
12.6.4.2.9. Respiratory
Diseases
12.6.4.2.10. Smoking
Cessation
12.6.4.2.11. Others
12.6.4.3. Rest of North America Digital Therapeutics Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
12.6.4.3.1. Business
to Business
12.6.4.3.2. Business
to Customer
12.6.4.4. Rest of North America Digital Therapeutics Market Revenue (US$
Mn) and Forecasts, By End User
12.6.4.4.1. Patients
12.6.4.4.2. Healthcare
Providers
12.6.4.4.3. Payers
12.6.4.4.4. Employers
12.6.4.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
12.7. Key
Segment for Channeling Investments
12.7.1. By
Country
12.7.2. By
Products
12.7.3. By
Application
12.7.4. By
Distribution Channel
12.7.5. By End
User
13. Europe Digital Therapeutics Market Analysis and Forecasts,
2019 - 2027
13.1. Overview
13.1.1. Europe
Digital Therapeutics Market Revenue (US$ Mn)
13.2. Europe
Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products
13.2.1. Software
13.2.2. Devices
13.3. Europe
Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application
13.3.1. Cardiovascular
Diseases
13.3.2. Central
Nervous System (CNS) Diseases
13.3.3. Diabetes
13.3.4. Gastrointestinal
Disorders (GID)
13.3.5. Mental
Health
13.3.6. Neurology
13.3.7. Obesity
13.3.8. Ophthalmology
13.3.9. Respiratory
Diseases
13.3.10. Smoking
Cessation
13.3.11. Others
13.4. Europe
Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.4.1. Business
to Business
13.4.2. Business
to Customer
13.5. Europe
Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User
13.5.1. Patients
13.5.2. Healthcare
Providers
13.5.3. Payers
13.5.4. Employers
13.5.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
13.6. Europe Digital
Therapeutics Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
13.6.1.1.1. Software
13.6.1.1.2. Devices
13.6.1.2. France Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.1.2.1. Cardiovascular
Diseases
13.6.1.2.2. Central
Nervous System (CNS) Diseases
13.6.1.2.3. Diabetes
13.6.1.2.4. Gastrointestinal
Disorders (GID)
13.6.1.2.5. Mental
Health
13.6.1.2.6. Neurology
13.6.1.2.7. Obesity
13.6.1.2.8. Ophthalmology
13.6.1.2.9. Respiratory
Diseases
13.6.1.2.10. Smoking
Cessation
13.6.1.2.11. Others
13.6.1.3. France Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
13.6.1.3.1. Business
to Business
13.6.1.3.2. Business
to Customer
13.6.1.4. France Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.1.4.1. Patients
13.6.1.4.2. Healthcare
Providers
13.6.1.4.3. Payers
13.6.1.4.4. Employers
13.6.1.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
13.6.2. The UK
13.6.2.1. The UK Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
13.6.2.1.1. Software
13.6.2.1.2. Devices
13.6.2.2. The UK Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.2.2.1. Cardiovascular
Diseases
13.6.2.2.2. Central
Nervous System (CNS) Diseases
13.6.2.2.3. Diabetes
13.6.2.2.4. Gastrointestinal
Disorders (GID)
13.6.2.2.5. Mental
Health
13.6.2.2.6. Neurology
13.6.2.2.7. Obesity
13.6.2.2.8. Ophthalmology
13.6.2.2.9. Respiratory
Diseases
13.6.2.2.10. Smoking
Cessation
13.6.2.2.11. Others
13.6.2.3. The UK Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
13.6.2.3.1. Business
to Business
13.6.2.3.2. Business
to Customer
13.6.2.4. The UK Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.2.4.1. Patients
13.6.2.4.2. Healthcare
Providers
13.6.2.4.3. Payers
13.6.2.4.4. Employers
13.6.2.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
13.6.3. Spain
13.6.3.1. Spain Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
13.6.3.1.1. Software
13.6.3.1.2. Devices
13.6.3.2. Spain Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.3.2.1. Cardiovascular
Diseases
13.6.3.2.2. Central
Nervous System (CNS) Diseases
13.6.3.2.3. Diabetes
13.6.3.2.4. Gastrointestinal
Disorders (GID)
13.6.3.2.5. Mental
Health
13.6.3.2.6. Neurology
13.6.3.2.7. Obesity
13.6.3.2.8. Ophthalmology
13.6.3.2.9. Respiratory
Diseases
13.6.3.2.10. Smoking
Cessation
13.6.3.2.11. Others
13.6.3.3. Spain Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
13.6.3.3.1. Business
to Business
13.6.3.3.2. Business
to Customer
13.6.3.4. Spain Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.3.4.1. Patients
13.6.3.4.2. Healthcare
Providers
13.6.3.4.3. Payers
13.6.3.4.4. Employers
13.6.3.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
13.6.4. Germany
13.6.4.1. Germany Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
13.6.4.1.1. Software
13.6.4.1.2. Devices
13.6.4.2. Germany Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.4.2.1. Cardiovascular
Diseases
13.6.4.2.2. Central
Nervous System (CNS) Diseases
13.6.4.2.3. Diabetes
13.6.4.2.4. Gastrointestinal
Disorders (GID)
13.6.4.2.5. Mental
Health
13.6.4.2.6. Neurology
13.6.4.2.7. Obesity
13.6.4.2.8. Ophthalmology
13.6.4.2.9. Respiratory
Diseases
13.6.4.2.10. Smoking
Cessation
13.6.4.2.11. Others
13.6.4.3. Germany Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
13.6.4.3.1. Business
to Business
13.6.4.3.2. Business
to Customer
13.6.4.4. Germany Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.4.4.1. Patients
13.6.4.4.2. Healthcare
Providers
13.6.4.4.3. Payers
13.6.4.4.4. Employers
13.6.4.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
13.6.5. Italy
13.6.5.1. Italy Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
13.6.5.1.1. Software
13.6.5.1.2. Devices
13.6.5.2. Italy Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.5.2.1. Cardiovascular
Diseases
13.6.5.2.2. Central
Nervous System (CNS) Diseases
13.6.5.2.3. Diabetes
13.6.5.2.4. Gastrointestinal
Disorders (GID)
13.6.5.2.5. Mental
Health
13.6.5.2.6. Neurology
13.6.5.2.7. Obesity
13.6.5.2.8. Ophthalmology
13.6.5.2.9. Respiratory
Diseases
13.6.5.2.10. Smoking
Cessation
13.6.5.2.11. Others
13.6.5.3. Italy Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
13.6.5.3.1. Business
to Business
13.6.5.3.2. Business
to Customer
13.6.5.4. Italy Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.5.4.1. Patients
13.6.5.4.2. Healthcare
Providers
13.6.5.4.3. Payers
13.6.5.4.4. Employers
13.6.5.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
13.6.6. Nordic
Countries
13.6.6.1. Nordic Countries Digital Therapeutics Market Revenue (US$ Mn)
and Forecasts, By Products
13.6.6.1.1. Software
13.6.6.1.2. Devices
13.6.6.2. Nordic Countries Digital Therapeutics Market Revenue (US$ Mn)
and Forecasts, By Application
13.6.6.2.1. Cardiovascular
Diseases
13.6.6.2.2. Central
Nervous System (CNS) Diseases
13.6.6.2.3. Diabetes
13.6.6.2.4. Gastrointestinal
Disorders (GID)
13.6.6.2.5. Mental
Health
13.6.6.2.6. Neurology
13.6.6.2.7. Obesity
13.6.6.2.8. Ophthalmology
13.6.6.2.9. Respiratory
Diseases
13.6.6.2.10. Smoking
Cessation
13.6.6.2.11. Others
13.6.6.3. Nordic Countries Digital Therapeutics Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
13.6.6.3.1. Business
to Business
13.6.6.3.2. Business
to Customer
13.6.6.4. Nordic Countries Digital Therapeutics Market Revenue (US$ Mn)
and Forecasts, By End User
13.6.6.4.1. Patients
13.6.6.4.2. Healthcare
Providers
13.6.6.4.3. Payers
13.6.6.4.4. Employers
13.6.6.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
13.6.6.5. Nordic Countries Digital Therapeutics Market Revenue (US$ Mn)
and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux
Union
13.6.7.1. Benelux Union Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
13.6.7.1.1. Software
13.6.7.1.2. Devices
13.6.7.2. Benelux Union Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.7.2.1. Cardiovascular
Diseases
13.6.7.2.2. Central
Nervous System (CNS) Diseases
13.6.7.2.3. Diabetes
13.6.7.2.4. Gastrointestinal
Disorders (GID)
13.6.7.2.5. Mental
Health
13.6.7.2.6. Neurology
13.6.7.2.7. Obesity
13.6.7.2.8. Ophthalmology
13.6.7.2.9. Respiratory
Diseases
13.6.7.2.10. Smoking
Cessation
13.6.7.2.11. Others
13.6.7.3. Benelux Union Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
13.6.7.3.1. Business
to Business
13.6.7.3.2. Business
to Customer
13.6.7.4. Benelux Union Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.7.4.1. Patients
13.6.7.4.2. Healthcare
Providers
13.6.7.4.3. Payers
13.6.7.4.4. Employers
13.6.7.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
13.6.7.5. Benelux Union Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The
Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of
Europe
13.6.8.1. Rest of Europe Digital Therapeutics Market Revenue (US$ Mn)
and Forecasts, By Products
13.6.8.1.1. Software
13.6.8.1.2. Devices
13.6.8.2. Rest of Europe Digital Therapeutics Market Revenue (US$ Mn)
and Forecasts, By Application
13.6.8.2.1. Cardiovascular
Diseases
13.6.8.2.2. Central
Nervous System (CNS) Diseases
13.6.8.2.3. Diabetes
13.6.8.2.4. Gastrointestinal
Disorders (GID)
13.6.8.2.5. Mental
Health
13.6.8.2.6. Neurology
13.6.8.2.7. Obesity
13.6.8.2.8. Ophthalmology
13.6.8.2.9. Respiratory
Diseases
13.6.8.2.10. Smoking
Cessation
13.6.8.2.11. Others
13.6.8.3. Rest of Europe Digital Therapeutics Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
13.6.8.3.1. Business
to Business
13.6.8.3.2. Business
to Customer
13.6.8.4. Rest of Europe Digital Therapeutics Market Revenue (US$ Mn)
and Forecasts, By End User
13.6.8.4.1. Patients
13.6.8.4.2. Healthcare
Providers
13.6.8.4.3. Payers
13.6.8.4.4. Employers
13.6.8.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
13.7. Key
Segment for Channeling Investments
13.7.1. By
Country
13.7.2. By
Products
13.7.3. By
Application
13.7.4. By
Distribution Channel
13.7.5. By End
User
14. Asia Pacific Digital Therapeutics Market Analysis and
Forecasts, 2019 - 2027
14.1. Overview
14.1.1. Asia
Pacific Digital Therapeutics Market Revenue (US$ Mn)
14.2. Asia
Pacific Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products
14.2.1. Software
14.2.2. Devices
14.3. Asia
Pacific Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Application
14.3.1. Cardiovascular
Diseases
14.3.2. Central
Nervous System (CNS) Diseases
14.3.3. Diabetes
14.3.4. Gastrointestinal
Disorders (GID)
14.3.5. Mental
Health
14.3.6. Neurology
14.3.7. Obesity
14.3.8. Ophthalmology
14.3.9. Respiratory
Diseases
14.3.10. Smoking
Cessation
14.3.11. Others
14.4. Asia
Pacific Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.4.1. Business
to Business
14.4.2. Business
to Customer
14.5. Asia
Pacific Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User
14.5.1. Patients
14.5.2. Healthcare
Providers
14.5.3. Payers
14.5.4. Employers
14.5.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
14.6. Asia
Pacific Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1. China Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
14.6.1.1.1. Software
14.6.1.1.2. Devices
14.6.1.2. China Digital Therapeutics Market Revenue (US$ Mn) and Forecasts,
By Application
14.6.1.2.1. Cardiovascular
Diseases
14.6.1.2.2. Central
Nervous System (CNS) Diseases
14.6.1.2.3. Diabetes
14.6.1.2.4. Gastrointestinal
Disorders (GID)
14.6.1.2.5. Mental
Health
14.6.1.2.6. Neurology
14.6.1.2.7. Obesity
14.6.1.2.8. Ophthalmology
14.6.1.2.9. Respiratory
Diseases
14.6.1.2.10. Smoking
Cessation
14.6.1.2.11. Others
14.6.1.3. China Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.6.1.3.1. Business
to Business
14.6.1.3.2. Business
to Customer
14.6.1.4. China Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.1.4.1. Patients
14.6.1.4.2. Healthcare
Providers
14.6.1.4.3. Payers
14.6.1.4.4. Employers
14.6.1.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
14.6.2. Japan
14.6.2.1. Japan Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
14.6.2.1.1. Software
14.6.2.1.2. Devices
14.6.2.2. Japan Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.2.2.1. Cardiovascular
Diseases
14.6.2.2.2. Central
Nervous System (CNS) Diseases
14.6.2.2.3. Diabetes
14.6.2.2.4. Gastrointestinal
Disorders (GID)
14.6.2.2.5. Mental
Health
14.6.2.2.6. Neurology
14.6.2.2.7. Obesity
14.6.2.2.8. Ophthalmology
14.6.2.2.9. Respiratory
Diseases
14.6.2.2.10. Smoking
Cessation
14.6.2.2.11. Others
14.6.2.3. Japan Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.6.2.3.1. Business
to Business
14.6.2.3.2. Business
to Customer
14.6.2.4. Japan Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.2.4.1. Patients
14.6.2.4.2. Healthcare
Providers
14.6.2.4.3. Payers
14.6.2.4.4. Employers
14.6.2.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
14.6.3. India
14.6.3.1. India Digital Therapeutics Market Revenue (US$ Mn) and Forecasts,
By Products
14.6.3.1.1. Software
14.6.3.1.2. Devices
14.6.3.2. India Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.3.2.1. Cardiovascular
Diseases
14.6.3.2.2. Central
Nervous System (CNS) Diseases
14.6.3.2.3. Diabetes
14.6.3.2.4. Gastrointestinal
Disorders (GID)
14.6.3.2.5. Mental
Health
14.6.3.2.6. Neurology
14.6.3.2.7. Obesity
14.6.3.2.8. Ophthalmology
14.6.3.2.9. Respiratory
Diseases
14.6.3.2.10. Smoking
Cessation
14.6.3.2.11. Others
14.6.3.3. India Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.6.3.3.1. Business
to Business
14.6.3.3.2. Business
to Customer
14.6.3.4. India Digital Therapeutics Market Revenue (US$ Mn) and Forecasts,
By End User
14.6.3.4.1. Patients
14.6.3.4.2. Healthcare
Providers
14.6.3.4.3. Payers
14.6.3.4.4. Employers
14.6.3.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
14.6.4. New
Zealand
14.6.4.1. New Zealand Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
14.6.4.1.1. Software
14.6.4.1.2. Devices
14.6.4.2. New Zealand Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.4.2.1. Cardiovascular
Diseases
14.6.4.2.2. Central
Nervous System (CNS) Diseases
14.6.4.2.3. Diabetes
14.6.4.2.4. Gastrointestinal
Disorders (GID)
14.6.4.2.5. Mental
Health
14.6.4.2.6. Neurology
14.6.4.2.7. Obesity
14.6.4.2.8. Ophthalmology
14.6.4.2.9. Respiratory
Diseases
14.6.4.2.10. Smoking
Cessation
14.6.4.2.11. Others
14.6.4.3. New Zealand Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.6.4.3.1. Business
to Business
14.6.4.3.2. Business
to Customer
14.6.4.4. New Zealand Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.4.4.1. Patients
14.6.4.4.2. Healthcare
Providers
14.6.4.4.3. Payers
14.6.4.4.4. Employers
14.6.4.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
14.6.5. Australia
14.6.5.1. Australia Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
14.6.5.1.1. Software
14.6.5.1.2. Devices
14.6.5.2. Australia Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.5.2.1. Cardiovascular
Diseases
14.6.5.2.2. Central
Nervous System (CNS) Diseases
14.6.5.2.3. Diabetes
14.6.5.2.4. Gastrointestinal
Disorders (GID)
14.6.5.2.5. Mental
Health
14.6.5.2.6. Neurology
14.6.5.2.7. Obesity
14.6.5.2.8. Ophthalmology
14.6.5.2.9. Respiratory
Diseases
14.6.5.2.10. Smoking
Cessation
14.6.5.2.11. Others
14.6.5.3. Australia Digital Therapeutics Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
14.6.5.3.1. Business
to Business
14.6.5.3.2. Business
to Customer
14.6.5.4. Australia Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.5.4.1. Patients
14.6.5.4.2. Healthcare
Providers
14.6.5.4.3. Payers
14.6.5.4.4. Employers
14.6.5.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
14.6.6. South
Korea
14.6.6.1. South Korea Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
14.6.6.1.1. Software
14.6.6.1.2. Devices
14.6.6.2. South Korea Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.6.2.1. Cardiovascular
Diseases
14.6.6.2.2. Central
Nervous System (CNS) Diseases
14.6.6.2.3. Diabetes
14.6.6.2.4. Gastrointestinal
Disorders (GID)
14.6.6.2.5. Mental
Health
14.6.6.2.6. Neurology
14.6.6.2.7. Obesity
14.6.6.2.8. Ophthalmology
14.6.6.2.9. Respiratory
Diseases
14.6.6.2.10. Smoking
Cessation
14.6.6.2.11. Others
14.6.6.3. South Korea Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.6.6.3.1. Business
to Business
14.6.6.3.2. Business
to Customer
14.6.6.4. South Korea Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.6.4.1. Patients
14.6.6.4.2. Healthcare
Providers
14.6.6.4.3. Payers
14.6.6.4.4. Employers
14.6.6.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
14.6.7. Southeast
Asia
14.6.7.1. Southeast Asia Digital Therapeutics Market Revenue (US$ Mn)
and Forecasts, By Products
14.6.7.1.1. Software
14.6.7.1.2. Devices
14.6.7.2. Southeast Asia Digital Therapeutics Market Revenue (US$ Mn)
and Forecasts, By Application
14.6.7.2.1. Cardiovascular
Diseases
14.6.7.2.2. Central
Nervous System (CNS) Diseases
14.6.7.2.3. Diabetes
14.6.7.2.4. Gastrointestinal
Disorders (GID)
14.6.7.2.5. Mental
Health
14.6.7.2.6. Neurology
14.6.7.2.7. Obesity
14.6.7.2.8. Ophthalmology
14.6.7.2.9. Respiratory
Diseases
14.6.7.2.10. Smoking
Cessation
14.6.7.2.11. Others
14.6.7.3. Southeast Asia Digital Therapeutics Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
14.6.7.3.1. Business
to Business
14.6.7.3.2. Business
to Customer
14.6.7.4. Southeast Asia Digital Therapeutics Market Revenue (US$ Mn)
and Forecasts, By End User
14.6.7.4.1. Patients
14.6.7.4.2. Healthcare
Providers
14.6.7.4.3. Payers
14.6.7.4.4. Employers
14.6.7.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
14.6.7.5. Southeast Asia Digital Therapeutics Market Revenue (US$ Mn)
and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest
of Southeast Asia
14.6.8. Rest of
Asia Pacific
14.6.8.1. Rest of Asia Pacific Digital Therapeutics Market Revenue (US$
Mn) and Forecasts, By Products
14.6.8.1.1. Software
14.6.8.1.2. Devices
14.6.8.2. Rest of Asia Pacific Digital Therapeutics Market Revenue (US$
Mn) and Forecasts, By Application
14.6.8.2.1. Cardiovascular
Diseases
14.6.8.2.2. Central
Nervous System (CNS) Diseases
14.6.8.2.3. Diabetes
14.6.8.2.4. Gastrointestinal
Disorders (GID)
14.6.8.2.5. Mental
Health
14.6.8.2.6. Neurology
14.6.8.2.7. Obesity
14.6.8.2.8. Ophthalmology
14.6.8.2.9. Respiratory
Diseases
14.6.8.2.10. Smoking
Cessation
14.6.8.2.11. Others
14.6.8.3. Rest of Asia Pacific Digital Therapeutics Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
14.6.8.3.1. Business
to Business
14.6.8.3.2. Business
to Customer
14.6.8.4. Rest of Asia Pacific Digital Therapeutics Market Revenue (US$
Mn) and Forecasts, By End User
14.6.8.4.1. Patients
14.6.8.4.2. Healthcare
Providers
14.6.8.4.3. Payers
14.6.8.4.4. Employers
14.6.8.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
14.7. Key
Segment for Channeling Investments
14.7.1. By
Country
14.7.2. By
Products
14.7.3. By
Application
14.7.4. By
Distribution Channel
14.7.5. By End
User
15. Middle East and Africa Digital Therapeutics Market Analysis
and Forecasts, 2019 - 2027
15.1. Overview
15.1.1. Middle
East and Africa Digital Therapeutics Market Revenue (US$ Mn)
15.2. Middle
East and Africa Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By
Products
15.2.1. Software
15.2.2. Devices
15.3. Middle
East and Africa Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By
Application
15.3.1. Cardiovascular
Diseases
15.3.2. Central
Nervous System (CNS) Diseases
15.3.3. Diabetes
15.3.4. Gastrointestinal
Disorders (GID)
15.3.5. Mental
Health
15.3.6. Neurology
15.3.7. Obesity
15.3.8. Ophthalmology
15.3.9. Respiratory
Diseases
15.3.10. Smoking
Cessation
15.3.11. Others
15.4. Middle
East and Africa Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.4.1. Business
to Business
15.4.2. Business
to Customer
15.5. Middle
East and Africa Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By
End User
15.5.1. Patients
15.5.2. Healthcare
Providers
15.5.3. Payers
15.5.4. Employers
15.5.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
15.6. Middle
East and Africa Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By
Country
15.6.1. Saudi
Arabia
15.6.1.1. Saudi Arabia Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
15.6.1.1.1. Software
15.6.1.1.2. Devices
15.6.1.2. Saudi Arabia Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.1.2.1. Cardiovascular
Diseases
15.6.1.2.2. Central
Nervous System (CNS) Diseases
15.6.1.2.3. Diabetes
15.6.1.2.4. Gastrointestinal
Disorders (GID)
15.6.1.2.5. Mental
Health
15.6.1.2.6. Neurology
15.6.1.2.7. Obesity
15.6.1.2.8. Ophthalmology
15.6.1.2.9. Respiratory
Diseases
15.6.1.2.10. Smoking
Cessation
15.6.1.2.11. Others
15.6.1.3. Saudi Arabia Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.6.1.3.1. Business
to Business
15.6.1.3.2. Business
to Customer
15.6.1.4. Saudi Arabia Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.1.4.1. Patients
15.6.1.4.2. Healthcare
Providers
15.6.1.4.3. Payers
15.6.1.4.4. Employers
15.6.1.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
15.6.2. UAE
15.6.2.1. UAE Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
15.6.2.1.1. Software
15.6.2.1.2. Devices
15.6.2.2. UAE Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.2.2.1. Cardiovascular
Diseases
15.6.2.2.2. Central
Nervous System (CNS) Diseases
15.6.2.2.3. Diabetes
15.6.2.2.4. Gastrointestinal
Disorders (GID)
15.6.2.2.5. Mental
Health
15.6.2.2.6. Neurology
15.6.2.2.7. Obesity
15.6.2.2.8. Ophthalmology
15.6.2.2.9. Respiratory
Diseases
15.6.2.2.10. Smoking
Cessation
15.6.2.2.11. Others
15.6.2.3. UAE Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.6.2.3.1. Business
to Business
15.6.2.3.2. Business
to Customer
15.6.2.4. UAE Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.2.4.1. Patients
15.6.2.4.2. Healthcare
Providers
15.6.2.4.3. Payers
15.6.2.4.4. Employers
15.6.2.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
15.6.3. Egypt
15.6.3.1. Egypt Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
15.6.3.1.1. Software
15.6.3.1.2. Devices
15.6.3.2. Egypt Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.3.2.1. Cardiovascular
Diseases
15.6.3.2.2. Central
Nervous System (CNS) Diseases
15.6.3.2.3. Diabetes
15.6.3.2.4. Gastrointestinal
Disorders (GID)
15.6.3.2.5. Mental
Health
15.6.3.2.6. Neurology
15.6.3.2.7. Obesity
15.6.3.2.8. Ophthalmology
15.6.3.2.9. Respiratory
Diseases
15.6.3.2.10. Smoking
Cessation
15.6.3.2.11. Others
15.6.3.3. Egypt Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.6.3.3.1. Business
to Business
15.6.3.3.2. Business
to Customer
15.6.3.4. Egypt Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.3.4.1. Patients
15.6.3.4.2. Healthcare
Providers
15.6.3.4.3. Payers
15.6.3.4.4. Employers
15.6.3.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
15.6.4. Kuwait
15.6.4.1. Kuwait Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
15.6.4.1.1. Software
15.6.4.1.2. Devices
15.6.4.2. Kuwait Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.4.2.1. Cardiovascular
Diseases
15.6.4.2.2. Central
Nervous System (CNS) Diseases
15.6.4.2.3. Diabetes
15.6.4.2.4. Gastrointestinal
Disorders (GID)
15.6.4.2.5. Mental
Health
15.6.4.2.6. Neurology
15.6.4.2.7. Obesity
15.6.4.2.8. Ophthalmology
15.6.4.2.9. Respiratory
Diseases
15.6.4.2.10. Smoking
Cessation
15.6.4.2.11. Others
15.6.4.3. Kuwait Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.6.4.3.1. Business
to Business
15.6.4.3.2. Business
to Customer
15.6.4.4. Kuwait Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.4.4.1. Patients
15.6.4.4.2. Healthcare
Providers
15.6.4.4.3. Payers
15.6.4.4.4. Employers
15.6.4.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
15.6.5. South
Africa
15.6.5.1. South Africa Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
15.6.5.1.1. Software
15.6.5.1.2. Devices
15.6.5.2. South Africa Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.5.2.1. Cardiovascular
Diseases
15.6.5.2.2. Central
Nervous System (CNS) Diseases
15.6.5.2.3. Diabetes
15.6.5.2.4. Gastrointestinal
Disorders (GID)
15.6.5.2.5. Mental
Health
15.6.5.2.6. Neurology
15.6.5.2.7. Obesity
15.6.5.2.8. Ophthalmology
15.6.5.2.9. Respiratory
Diseases
15.6.5.2.10. Smoking
Cessation
15.6.5.2.11. Others
15.6.5.3. South Africa Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.6.5.3.1. Business
to Business
15.6.5.3.2. Business
to Customer
15.6.5.4. South Africa Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.5.4.1. Patients
15.6.5.4.2. Healthcare
Providers
15.6.5.4.3. Payers
15.6.5.4.4. Employers
15.6.5.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
15.6.6. Rest of
Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Digital Therapeutics Market
Revenue (US$ Mn) and Forecasts, By Products
15.6.6.1.1. Software
15.6.6.1.2. Devices
15.6.6.2. Rest of Middle East & Africa Digital Therapeutics Market
Revenue (US$ Mn) and Forecasts, By Application
15.6.6.2.1. Cardiovascular
Diseases
15.6.6.2.2. Central
Nervous System (CNS) Diseases
15.6.6.2.3. Diabetes
15.6.6.2.4. Gastrointestinal
Disorders (GID)
15.6.6.2.5. Mental
Health
15.6.6.2.6. Neurology
15.6.6.2.7. Obesity
15.6.6.2.8. Ophthalmology
15.6.6.2.9. Respiratory
Diseases
15.6.6.2.10. Smoking
Cessation
15.6.6.2.11. Others
15.6.6.3. Rest of Middle East & Africa Digital Therapeutics Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
15.6.6.3.1. Business
to Business
15.6.6.3.2. Business
to Customer
15.6.6.4. Rest of Middle East & Africa Digital Therapeutics Market
Revenue (US$ Mn) and Forecasts, By End User
15.6.6.4.1. Patients
15.6.6.4.2. Healthcare
Providers
15.6.6.4.3. Payers
15.6.6.4.4. Employers
15.6.6.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
15.7. Key
Segment for Channeling Investments
15.7.1. By
Country
15.7.2. By
Products
15.7.3. By
Application
15.7.4. By
Distribution Channel
15.7.5. By End
User
16. Latin America Digital Therapeutics Market Analysis and
Forecasts, 2019 - 2027
16.1. Overview
16.1.1. Latin
America Digital Therapeutics Market Revenue (US$ Mn)
16.2. Latin
America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Products
16.2.1. Software
16.2.2. Devices
16.3. Latin
America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By
Application
16.3.1. Cardiovascular
Diseases
16.3.2. Central
Nervous System (CNS) Diseases
16.3.3. Diabetes
16.3.4. Gastrointestinal
Disorders (GID)
16.3.5. Mental
Health
16.3.6. Neurology
16.3.7. Obesity
16.3.8. Ophthalmology
16.3.9. Respiratory
Diseases
16.3.10. Smoking
Cessation
16.3.11. Others
16.4. Latin
America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.4.1. Business
to Business
16.4.2. Business
to Customer
16.5. Latin
America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By End User
16.5.1. Patients
16.5.2. Healthcare
Providers
16.5.3. Payers
16.5.4. Employers
16.5.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
16.6. Latin
America Digital Therapeutics Market Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
16.6.1.1.1. Software
16.6.1.1.2. Devices
16.6.1.2. Brazil Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
16.6.1.2.1. Cardiovascular
Diseases
16.6.1.2.2. Central
Nervous System (CNS) Diseases
16.6.1.2.3. Diabetes
16.6.1.2.4. Gastrointestinal
Disorders (GID)
16.6.1.2.5. Mental
Health
16.6.1.2.6. Neurology
16.6.1.2.7. Obesity
16.6.1.2.8. Ophthalmology
16.6.1.2.9. Respiratory
Diseases
16.6.1.2.10. Smoking
Cessation
16.6.1.2.11. Others
16.6.1.3. Brazil Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.6.1.3.1. Business
to Business
16.6.1.3.2. Business
to Customer
16.6.1.4. Brazil Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
16.6.1.4.1. Patients
16.6.1.4.2. Healthcare
Providers
16.6.1.4.3. Payers
16.6.1.4.4. Employers
16.6.1.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
16.6.2. Argentina
16.6.2.1. Argentina Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Products
16.6.2.1.1. Software
16.6.2.1.2. Devices
16.6.2.2. Argentina Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Application
16.6.2.2.1. Cardiovascular
Diseases
16.6.2.2.2. Central
Nervous System (CNS) Diseases
16.6.2.2.3. Diabetes
16.6.2.2.4. Gastrointestinal
Disorders (GID)
16.6.2.2.5. Mental
Health
16.6.2.2.6. Neurology
16.6.2.2.7. Obesity
16.6.2.2.8. Ophthalmology
16.6.2.2.9. Respiratory
Diseases
16.6.2.2.10. Smoking
Cessation
16.6.2.2.11. Others
16.6.2.3. Argentina Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.6.2.3.1. Business
to Business
16.6.2.3.2. Business
to Customer
16.6.2.4. Argentina Digital Therapeutics Market Revenue (US$ Mn) and
Forecasts, By End User
16.6.2.4.1. Patients
16.6.2.4.2. Healthcare
Providers
16.6.2.4.3. Payers
16.6.2.4.4. Employers
16.6.2.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
16.6.3. Rest of
Latin America
16.6.3.1. Rest of Latin America Digital Therapeutics Market Revenue (US$
Mn) and Forecasts, By Products
16.6.3.1.1. Software
16.6.3.1.2. Devices
16.6.3.2. Rest of Latin America Digital Therapeutics Market Revenue (US$
Mn) and Forecasts, By Application
16.6.3.2.1. Cardiovascular
Diseases
16.6.3.2.2. Central
Nervous System (CNS) Diseases
16.6.3.2.3. Diabetes
16.6.3.2.4. Gastrointestinal
Disorders (GID)
16.6.3.2.5. Mental
Health
16.6.3.2.6. Neurology
16.6.3.2.7. Obesity
16.6.3.2.8. Ophthalmology
16.6.3.2.9. Respiratory
Diseases
16.6.3.2.10. Smoking
Cessation
16.6.3.2.11. Others
16.6.3.3. Rest of Latin America Digital Therapeutics Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
16.6.3.3.1. Business
to Business
16.6.3.3.2. Business
to Customer
16.6.3.4. Rest of Latin America Digital Therapeutics Market Revenue (US$
Mn) and Forecasts, By End User
16.6.3.4.1. Patients
16.6.3.4.2. Healthcare
Providers
16.6.3.4.3. Payers
16.6.3.4.4. Employers
16.6.3.4.5. Other
(Fitness and Wellness Centers, Gym, Etc.)
16.7. Key
Segment for Channeling Investments
16.7.1. By
Country
16.7.2. By
Products
16.7.3. By
Application
16.7.4. By
Distribution Channel
16.7.5. By End
User
17. Competitive Benchmarking
17.1. Brand
Benchmarking
17.2. Market
Share Analysis, 2018
17.3. Global
Presence and Growth Strategies
17.3.1. Mergers
and Acquisitions
17.3.2. Product
Launches
17.3.3. Investments
Trends
17.3.4. R&D
Initiatives
18. Player Profiles
18.1. Adherium
18.1.1. Company
Details
18.1.2. Company
Overview
18.1.3. Product
Offerings
18.1.4. Key
Developments
18.1.5. Financial
Analysis
18.1.6. SWOT
Analysis
18.1.7. Business
Strategies
18.2. BigHealth
18.2.1. Company
Details
18.2.2. Company
Overview
18.2.3. Product
Offerings
18.2.4. Key
Developments
18.2.5. Financial
Analysis
18.2.6. SWOT
Analysis
18.2.7. Business
Strategies
18.3. BLUE MESA
HEALTH
18.3.1. Company
Details
18.3.2. Company
Overview
18.3.3. Product
Offerings
18.3.4. Key
Developments
18.3.5. Financial
Analysis
18.3.6. SWOT
Analysis
18.3.7. Business
Strategies
18.4. CANARY
HEALTH
18.4.1. Company
Details
18.4.2. Company
Overview
18.4.3. Product
Offerings
18.4.4. Key
Developments
18.4.5. Financial
Analysis
18.4.6. SWOT
Analysis
18.4.7. Business
Strategies
18.5. Chrono
Therapeutics Inc.,
18.5.1. Company
Details
18.5.2. Company
Overview
18.5.3. Product
Offerings
18.5.4. Key Developments
18.5.5. Financial
Analysis
18.5.6. SWOT
Analysis
18.5.7. Business
Strategies
18.6. Diabetes
Digital Media Ltd
18.6.1. Company
Details
18.6.2. Company
Overview
18.6.3. Product
Offerings
18.6.4. Key
Developments
18.6.5. Financial
Analysis
18.6.6. SWOT
Analysis
18.6.7. Business
Strategies
18.7. Digital
Therapeutics, Inc.
18.7.1. Company
Details
18.7.2. Company
Overview
18.7.3. Product
Offerings
18.7.4. Key
Developments
18.7.5. Financial
Analysis
18.7.6. SWOT
Analysis
18.7.7. Business
Strategies
18.8. Dthera
Sciences
18.8.1. Company
Details
18.8.2. Company
Overview
18.8.3. Product
Offerings
18.8.4. Key
Developments
18.8.5. Financial
Analysis
18.8.6. SWOT
Analysis
18.8.7. Business
Strategies
18.9. Firstbeat
18.9.1. Company
Details
18.9.2. Company
Overview
18.9.3. Product
Offerings
18.9.4. Key
Developments
18.9.5. Financial
Analysis
18.9.6. SWOT
Analysis
18.9.7. Business
Strategies
18.10. GINGER.IO
18.10.1. Company
Details
18.10.2. Company
Overview
18.10.3. Product
Offerings
18.10.4. Key
Developments
18.10.5. Financial
Analysis
18.10.6. SWOT
Analysis
18.10.7. Business
Strategies
18.11. Glooko,
Inc.
18.11.1. Company
Details
18.11.2. Company
Overview
18.11.3. Product
Offerings
18.11.4. Key
Developments
18.11.5. Financial
Analysis
18.11.6. SWOT
Analysis
18.11.7. Business
Strategies
18.12. Limbix
18.12.1. Company
Details
18.12.2. Company
Overview
18.12.3. Product
Offerings
18.12.4. Key
Developments
18.12.5. Financial
Analysis
18.12.6. SWOT
Analysis
18.12.7. Business
Strategies
18.13. Livongo
Health
18.13.1. Company
Details
18.13.2. Company
Overview
18.13.3. Product
Offerings
18.13.4. Key
Developments
18.13.5. Financial
Analysis
18.13.6. SWOT
Analysis
18.13.7. Business
Strategies
18.14. MANGO
HEALTH
18.14.1. Company
Details
18.14.2. Company
Overview
18.14.3. Product
Offerings
18.14.4. Key
Developments
18.14.5. Financial
Analysis
18.14.6. SWOT
Analysis
18.14.7. Business
Strategies
18.15. Merck
& Co., Inc.
18.15.1. Company
Details
18.15.2. Company
Overview
18.15.3. Product
Offerings
18.15.4. Key
Developments
18.15.5. Financial
Analysis
18.15.6. SWOT
Analysis
18.15.7. Business
Strategies
18.16. Noom,
Inc.
18.16.1. Company
Details
18.16.2. Company
Overview
18.16.3. Product
Offerings
18.16.4. Key
Developments
18.16.5. Financial
Analysis
18.16.6. SWOT
Analysis
18.16.7. Business
Strategies
18.17. Novartis
AG
18.17.1. Company
Details
18.17.2. Company
Overview
18.17.3. Product
Offerings
18.17.4. Key
Developments
18.17.5. Financial
Analysis
18.17.6. SWOT
Analysis
18.17.7. Business
Strategies
18.18. Omada
Health, Inc.
18.18.1. Company
Details
18.18.2. Company
Overview
18.18.3. Product
Offerings
18.18.4. Key
Developments
18.18.5. Financial
Analysis
18.18.6. SWOT
Analysis
18.18.7. Business
Strategies
18.19. Propeller
Health
18.19.1. Company
Details
18.19.2. Company
Overview
18.19.3. Product
Offerings
18.19.4. Key
Developments
18.19.5. Financial
Analysis
18.19.6. SWOT
Analysis
18.19.7. Business
Strategies
18.20. Proteus
Digital Health
18.20.1. Company
Details
18.20.2. Company
Overview
18.20.3. Product
Offerings
18.20.4. Key
Developments
18.20.5. Financial
Analysis
18.20.6. SWOT
Analysis
18.20.7. Business
Strategies
18.21. WellDoc,
Inc.
18.21.1. Company
Details
18.21.2. Company
Overview
18.21.3. Product
Offerings
18.21.4. Key
Developments
18.21.5. Financial
Analysis
18.21.6. SWOT
Analysis
18.21.7. Business
Strategies
19. Key Findings
Note: This ToC is tentative and can
be changed according to the research study conducted during the course of
report completion.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com


Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.
